U.S. Insurers Must Cover 8 COVID At-Home Tests a Month: White House
TUESDAY, Jan. 11, 2022 (HealthDay News) — Private insurers will have to cover the cost of eight at-home COVID tests per person per month as of Saturday, the Biden administration announced Monday.“Today’s action further removes financial barriers and …
Learn MoreMedicare May Rethink Premium Hike for Pricey Alzheimer’s Drug
MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm.U.S. Health and Human Services Secretary Xavier Becerra’s…
Learn MoreModerna CEO Says 4th COVID Dose May Be Needed Next Fall
FRIDAY, JAN. 6, 2022 (HealthDay News) — A fourth COVID shot may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday.While the booster that millions of Americans received thi…
Learn MoreWhite House Finalizes Plan to Send Americans Free COVID Rapid Tests
FRIDAY, Jan. 6, 2022 (HealthDay News) — The final touches are being put on the White House’s plan to deliver 500 million free coronavirus rapid at-home test kits to households across America.The administration will launch a website where people can r…
Learn MoreSome At-Home Tests May Miss Omicron in Early Stages of Infection
THURSDAY, Jan. 6, 2022 (HealthDay News) — The Abbott BinaxNOW and Quidel QuickVue — two widely used rapid at-home COVID tests — may sometimes fail to spot evidence of the Omicron variant in the first days after infection, even when people are carry…
Learn MoreCDC Panel Backs FDA Approval of Boosters for Those Aged 12-15
WEDNESDAY, Jan. 5, 2022 (HealthDay News) — An advisory panel to the U.S. Centers for Disease Control and Prevention on Wednesday backed the emergency use approval of Pfizer’s booster shots for those between the ages of 12 and 17. The Food and Drug A…
Learn MoreCDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period …
Learn MoreCDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period …
Learn MoreCDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period …
Learn MoreU.S. Hospitals Seeing Record Numbers of Young COVID Patients
TUESDAY, Jan. 4, 2022 (HealthDay News) — COVID-19 hospitalizations among children are surging across the United States just as students return to school and the highly transmissible Omicron variant begins to dominate the country.At least nine states …
Learn More